Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02903420
NA

A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)

Sponsor: Edwards Lifesciences

View on ClinicalTrials.gov

Summary

A single arm, prospective, open, non-randomized, Japanese multicenter trial to evaluate the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve System (Model: 9600TFX) in the treatment of symptomatic severe aortic stenosis patients on chronic dialysis, who are determined by the heart team to be unable to undergo safe open surgical therapy and have the benefits of the study valve implantation. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Official title: A Clinical Trial for Transcatheter Aortic Valve Implantation in Chronic Dialysis Patients With Aortic Valve Stenosis

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

38

Start Date

2016-09

Completion Date

2026-01

Last Updated

2024-09-25

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

Implantation of Edwards SAPIEN 3 Transcatheter Heart Valve (Model: 9600TFX) via transfemoral, transapical or transaortic approach.

Locations (2)

Osaka University Hospital

Suita, Osaka, Japan

Keio University Hospital

Shinjuku-Ku, Tokyo, Japan